Potiga Risk of Vision Loss, Skin Discoloration Require New Long-Term Study
The FDA has ordered the makers of Potiga to conduct a long-term study on skin discoloration and retina pigment changes caused by the epilepsy drug.
The FDA has ordered the makers of Potiga to conduct a long-term study on skin discoloration and retina pigment changes caused by the epilepsy drug.
A Potiga black box warning will be added by the FDA about the risk of side effects of the epilepsy drug that may cause eye damage, vision loss and skin…
Federal health officials have issued a safety alert about potential side effects of Potiga, an anti-seizure medication that has been linked to reports of patients experiencing blue skin discoloration and…